Anzeige
Mehr »
Login
Samstag, 29.03.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Kritischer Rohstoff, strategische Wende: Warum diese Aktie jetzt auf das Radar kluger Investoren gehört
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A11664 | ISIN: US03209R1032 | Ticker-Symbol: 29A
Tradegate
28.03.25
18:49 Uhr
26,040 Euro
-0,220
-0,84 %
1-Jahres-Chart
AMPHASTAR PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
AMPHASTAR PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
26,14026,36028.03.
26,00026,52028.03.

Aktuelle News zur AMPHASTAR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrAmphastar Pharmaceuticals, Inc.: International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award1.046Recognized for contributions to address shortage of epinephrine injection, 0.1 mg/mL syringes RANCHO CUCAMONGA, CA / ACCESS Newswire / March 28, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)...
► Artikel lesen
21.03.Amphastar stock target cut to $32 by Piper Sandler, maintains neutral1
AMPHASTAR Aktie jetzt für 0€ handeln
06.03.Finanzvorstand von Amphastar Pharmaceuticals verkauft Aktien im Wert von 116.515 US-Dollar8
05.03.Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference386RANCHO CUCAMONGA, CA / ACCESS Newswire / March 5, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations...
► Artikel lesen
03.03.Amphastar Pharmaceuticals, Inc. - 10-K, Annual Report4
28.02.Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds9
27.02.Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024269Reports Net Revenues of $186.5 Million for the Three Months Ended December 31, 2024 RANCHO CUCAMONGA, CA / ACCESS Newswire / February 27, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar"...
► Artikel lesen
27.02.Amphastar Pharmaceuticals, Inc. - 8-K, Current Report4
20.02.Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025277RANCHO CUCAMONGA, CA / ACCESS Newswire / February 20, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its Fourth quarter of 2024 ended December...
► Artikel lesen
17.02.Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Sees Large Drop in Short Interest5
04.02.Piper Sandler cuts Amphastar stock rating, slashes price target14
08.01.Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference328RANCHO CUCAMONGA, CA / ACCESSWIRE / January 8, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at the...
► Artikel lesen
06.01.Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 1-Year Low - What's Next?3
16.12.24Führungskraft von Amphastar Pharmaceuticals verkauft Aktien im Wert von 672.815 US-Dollar6
30.11.24Why Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now?7
26.11.24Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference690RANCHO CUCAMONGA, CA / ACCESSWIRE / November 26, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Dan Dischner SVP of Corp. Communication, will participate...
► Artikel lesen
13.11.24Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference411RANCHO CUCAMONGA, CA / ACCESSWIRE / November 13, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will...
► Artikel lesen
08.11.24Amphastar CFO William J. Peters verkauft Aktien für 386.523 US-Dollar8
07.11.24Amphastar Pharmaceuticals, Inc. - 10-Q, Quarterly Report7
06.11.24Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024358Reports Net Revenues of $191.2 Million for the Three Months Ended September 30, 2024RANCHO CUCAMONGA, CA / ACCESSWIRE / November 6, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar"...
► Artikel lesen
Seite:  Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1